Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.

By Robert M. Bilder, R. S. Goldman, D. Robinson, G. Reiter, L. Bell, J. Bates, E. Pappadopulos, D. Willson, Jose Alvir, M. Woerner and 3 more. American Journal of Psychiatry, 2000

934 citations recorded by the source corpus.

Subfields: Cognitive Neuroscience, Psychiatry and Mental health, Philosophy

View Paper: https://www.semanticscholar.org/paper/40e4e4f9447e3092f89802909ea5cf5b71029939

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cognitive Neuroscience

1. Michael F. Green
2. J. Cohen
3. Deanna M. Barch
4. R. Heaton
5. Daniel R. Weinberger
6. R. Kern
7. R. Keefe
8. Stephen V. Faraone

In Psychiatry and Mental health

1. Michael F. Green
2. R. Keefe
3. Daniel R. Weinberger
4. R. Heaton
5. R. Kern
6. Larry J. Seidman
7. R. Mesholam-Gately
8. Stephen V. Faraone

In Philosophy

1. Daniel R. Weinberger
2. J. Cohen
3. Terry E. Goldberg
4. S. Marder

Citations in the corpus

• The Neuropsychology of Schizophrenia (2019, methodology): “Several candidates for such a differential deficit have been proposed, notably attention (Weickert et al. , 2000), verbal learning and memory (Bilder et al. , 2000; McKenna et al. , 1990; Saykin et al. , 1991) and executive functions (Evans et al. , 1997; Riley et al. , 2000; Weickert et al. , 2000).”
• Neurocognition in first-episode schizophrenia: a meta-analytic review. (2009, methodology): “…1998) and methods used by other groups who characterized neuropsychological functioning in schizophrenia, particularly FE schizophrenia (e.g., Bilder et al., 1995; 1988; 2000; Bilder, Mukherjee, Rieder, & Pandurangi, 1985; Blanchard & Neale, 1994; Heinrichs & Zakzanis, 1998; Hoff, Riordan,…”
• Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. (2005, background): “(10), who reported significant correlations between the SANS negative symptom scores and memory,”
• A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. (2005, neutral): “Patients with schizophrenia typically perform one to two standard deviations below normal on a variety of measures, especially those that assess executive functions, verbal skills, processing speed, and attention (Bilder et al., 2000; Fuller et al., 2002; Heinrichs and Zakzanis, 1998; Hoff et al., 1”
• Cognitive deficits and functional outcome in schizophrenia (2006, neutral): “All rights reserved 531”
• Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. (2004, methodology): “After stabilization of the initial psychotic episode, subjects were tested with a comprehensive cognitive battery that included 41 tests (11).”
• Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. (2004, background): “In addition, any such changes in functioning would heavily depend on factors that are typically beyond the control of clinical trial studies, including availability of psychosocial rehabilitation, social support networks, and local school and vocational opportunities.”